A.M. Vitals: FDA Extends Merck KGaA’s Cladribine Review


Published On: November 27th, 2010

Also: safety problems persist; NICE nixes Novartis’s Afinitor; secondhand smoke stats.

See original here:
A.M. Vitals: FDA Extends Merck KGaA’s Cladribine Review



Loading...


Comments are closed.